Clinical Trials Browser

Phase 1/2 × Imatinib Mesylate × Gastrointestinal × Clear all

NCT01991379 2025-12-04

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1/2 Active not recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03609424 2023-01-03

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

Phase 1/2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01275222 2021-06-25

Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors

Phase 1/2 Completed

117 enrolled 18 charts

GastrointestinalSarcoma

Digestive System Neoplasms, Sarcoma, Stomach Neoplasms, Gastrointestinal Stromal Tumors

NCT00867334 2020-06-30

NITMEC

Phase 1/2 Completed

10 enrolled 9 charts

Gastrointestinal

Colorectal Neoplasms

NCT02257541 2020-03-30

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1/2 Completed

16 enrolled 14 charts

GastrointestinalSarcoma

Advanced Gastrointestinal Stromal Tumor (GIST)

NCT00784446 2013-01-07

First-line Therapy of Stage IV Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00006357 2012-09-24

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Phase 1/2 Completed

GastrointestinalGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous